Picture of Biorestorative Therapies logo

BRTX — Biorestorative Therapies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: BioRestorative Therapies Announces First Patient Enrolled For The Company’s Phase 2 Clinical Trial To Treat Chronic Lumbar Disc Disease (CLDD)

June 30 (Reuters) - BioRestorative Therapies Inc  BRTX.O :
    * BIORESTORATIVE THERAPIES ANNOUNCES FIRST PATIENT ENROLLED
FOR
THE COMPANY’S PHASE 2 CLINICAL TRIAL TO TREAT CHRONIC LUMBAR
DISC DISEASE (CLDD)

Source text for Eikon:  ID:nGNX6t4Y3G 
Further company coverage:  BRTX.O

Recent news on Biorestorative Therapies

See all news